Literature DB >> 7948949

Forms and functions of p53.

J Milner1.   

Abstract

There is evidence that wild-type p53 can both promote and suppress cell proliferation and these opposing functions correlate with alternative conformations of the p53 protein. In the light of more recent evidence I now propose that wild-type p53 can adopt at least three different forms, each of which correlates with a defined function in cell growth control. The three forms are most simply defined by reactivity with two monoclonal antibodies, PAb421 and PAb1620. One form (421 degrees/1620+) suppresses cell growth and maintains quiescence, and a second form (421+/1620 degrees) activates and promotes cell proliferation. The third form (421+/1620+) acts as a differential sensor for incoming positive and negative growth regulatory signals and can be converted either to the suppressor or to the promoter form for cell growth. Regulation of p53 tertiary structure involves redox modulation and phosphorylation, and offers a novel rationale for anti-cancer therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7948949

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  10 in total

Review 1.  Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo?

Authors:  C Salvat; C Aquaviva; I Jariel-Encontre; P Ferrara; M Pariat; A M Steff; S Carillo; M Piechaczyk
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

2.  Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin.

Authors:  Z P Ren; A Ahmadian; F Pontén; M Nistér; C Berg; J Lundeberg; M Uhlén; J Pontén
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

3.  Gly-Ala repeats induce position- and substrate-specific regulation of 26 S proteasome-dependent partial processing.

Authors:  Chrysoula Daskalogianni; Sébastien Apcher; Marco M Candeias; Nadia Naski; Fabien Calvo; Robin Fåhraeus
Journal:  J Biol Chem       Date:  2008-08-29       Impact factor: 5.157

4.  Proteolysis by calpains: a possible contribution to degradation of p53.

Authors:  M Pariat; S Carillo; M Molinari; C Salvat; L Debüssche; L Bracco; J Milner; M Piechaczyk
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

5.  Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA.

Authors:  P Balagurumoorthy; H Sakamoto; M S Lewis; N Zambrano; G M Clore; A M Gronenborn; E Appella; R E Harrington
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

6.  Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90.

Authors:  M V Blagosklonny; J Toretsky; S Bohen; L Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

7.  p53 status of newly established acute myeloid leukaemia cell lines.

Authors:  A Zheng; K Castren; M Säily; E R Savolainen; P Koistinen; K Vähäkangas
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

8.  p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.

Authors:  Fang Zheng; Qin Tang; JingJing Wu; ShunYu Zhao; ZhanYang Liang; Liuning Li; WanYin Wu; Swei Hann
Journal:  J Exp Clin Cancer Res       Date:  2014-04-26

9.  Temperature-sensitive ovarian carcinoma cell line (OvBH-1).

Authors:  Julia K Bar; Antonina Harlozinska; Sabine Kartarius; Mathias Montenarh; Ewa Wyrodek; Jan M Rodriguez Parkitna; Marian Kochman; Andrzej Ozyhar
Journal:  Jpn J Cancer Res       Date:  2002-09

Review 10.  MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?

Authors:  Samy A Azer
Journal:  J Clin Med       Date:  2018-03-27       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.